...

Artículo

Unveiling the Immune effects of AHR in tumors: a decade of insights from bibliometric analysis (2010–2023)

Resumen

Background: The Aryl Hydrocarbon Receptor (AHR) is a transcription factor that regulates several biological processes. Its potential in anti-tumor immunotherapy is becoming clearer, yet no bibliometric studies on this topic exist. This study aims to understand the current research landscape and identify future directions through a bibliometric analysis of AHR’s anti-tumor immunological effects. Methods : We conducted a comprehensive bibliometric analysis of AHR antitumor immunotherapy papers in the Web of Science Core Collection. Various aspects of the publications were analyzed, and research hotspots and future trends were identified using scientific bibliometric tools and statistical methods. Results: We collected 592 English papers published between 2010 and 2023, with an almost annual increase. Most publications were from the USA, followed by China, Germany, and Italy. The journal “Frontiers in Immunology” had the most papers, and the most cited paper was Christiane A. Opitz’s “An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.” The research is centered around AHR gene expression, with a growing focus on intestinal disease and the development of Programmed cell death ligand 1 (PD-L1) drugs. Conclusion: This bibliometric study highlights the significance of AHR in immunomodulatory research, outlining the research trends and key contributors. It suggests AHR’s immune effects may mediate the process of colitis cancer transformation, providing valuable insights for future anti-tumor immunotherapy strategies based on AHR.
Liu, Qian (58043907500); Yang, Shijie (59167076100); Chen, HeCheng (57203946435)
Global trends and hotspots in the study of the effects of PM2.5 on ischemic stroke
2024
10.1186/s41043-024-00622-3
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85202738639&doi=10.1186%2fs41043-024-00622-3&partnerID=40&md5=2f80b4bf91836970169230f4633fc742
Cerebrovascular Disease Department, Gansu Provincial Hospital, No.204 West Donggang Road, Gansu Province, Lanzhou, 730000, China; Key Laboratory of Cerebrovascular Disease of Gansu Province, Gansu Provincial Hospital, Gansu, Lanzhou, China; The First Clinical Medical College of Lanzhou University, Lanzhou, China
All Open Access; Gold Open Access
Scopus
Artículo obtenido de:
Scopus
Fuente
0 0 votos
Califica el artículo
Subscribirse
Notificación de
Campus Samborondón
Vía Samborondón Km. 13.5
Call Center: 5150400
metricas@ecotec.edu.ec
Facebook Instagram Youtube

Mapa del sitio

Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.